Sign in
Taking people in United StatesNo phase

Hormone-like steroids in children with Tourette syndrome

Studies steroid hormone patterns in boys and girls with Tourette syndrome.

Key facts

Who runs it
University of Utah
Where
Salt Lake City, United StatesSee the site
Trial code
Registry title
Exploring the Role of Neuroactive Steroids in Tourette Syndrome
Status
Recruiting
People taking part
120 people, planned
Started
15 May 2023
Expected to end
31 Oct 2027
Type of study
Interventional
Treatments tested
  • Tic suppression task
Record updated
6 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children aged 8 to 12 with Tourette syndrome, a condition with tics. It also takes children without any tic disorder as a comparison group.

Age
8 to 12 years
Sex
Boys and girls
Disease stage
Children with tics must have a diagnosis of Tourette syndrome. Comparison children must have no tic disorder.
Earlier treatment
Children cannot join if they use therapies that can change hormone levels. They also cannot join if they take drugs that may change stress sensitivity, such as antidepressants and anxiolytics.
Biomarker or test result
Sexual development must be confirmed by a parent and/or by self-reported Tanner stage of pubic hair development.

Main reasons for not taking part

  • Major psychiatric disorders, such as psychotic disorder, autism spectrum disorder, conduct disorder or substance use disorder
  • Other neurological disorders
  • Clinically significant hormone (endocrine) disorders
  • Use of therapies that can change hormone levels
  • Drugs that may change stress sensitivity, such as antidepressants and anxiolytics

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Diagnostic criteria of TS for cases (and lack of any tic disorders for controls)
  • Age between 8 and 12 years old (this age range is to ensure that TS participants can perform the tic suppression task)
  • confirmation of sexual development by parent and/or self-reported Tanner stage of pubic hair development

Who cannot take part

  • use of therapies that can modify hormonal profile
  • major psychiatric disorders such as a psychotic disorder, autism spectrum disorder, conduct disorder, and substance use disorder
  • other neurological disorders
  • clinically significant endocrinological disorders
  • pharmacotherapies that may change stress sensitivity, such as antidepressants and anxiolytics

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 12 years old?

Where in United States

  • University of UtahSalt Lake City, United StatesContact: Michael Himle, PhDTaking people

About the trial

What the trial wants to find out

Tourette syndrome (TS) is a disabling neurodevelopmental disorder characterized by motor and phonic tics. The studies proposed in this application will explore the endocrine mechanisms underlying two of the least well-understood biological characteristics of TS, namely its marked male predominance and stress susceptibility. In particular, our exploratory studies will characterize the steroid profile in TS-affected boys and girls to identify novel potential biomarkers and therapeutic targets for this disorder.

The group in the trial

  • Tic suppressionTreatment being tested

    Children with tics will undergo a tic suppression experimental paradigm.

    Treatment: Tic suppression task

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Exploring the Role of Neuroactive Steroids in Tourette Syndrome
Plain-language title
Hormone-like steroids in children with Tourette syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05281445, who can take part
Record updated
6 October 2026